Ozempic, Wegovy, and Zepbound could prove useful for a range of conditions, from heart disease to addiction.
he new weight-loss drugs Wegovy and Zepbound are in high demand, and the clamoring will only increase in coming years, experts predict. That's because drugs like these, which rely at least in part on the appetite-regulating hormone GLP-1, are being investigated not just for weight loss and diabetes, but also for a wide range of other conditions.
Some of that benefit to the heart may come from the weight loss itself, since weight can have an adverse effect on the heart.
Beyond that, however, incretins could address some of the biological processes involved in fertility. About 10% of women of childbearing age in the U.S. have polycystic ovary syndrome , which is the most common cause of infertility. PCOS is a hormone disorder, and it can be driven by insulin resistance or increased levels of insulin in the body.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
New study shows NHS digital weight management program is effective at achieving clinically meaningful weight lossThe success of a national weight management program has been highlighted in a study in the journal Obesity. The 12-week NHS Digital Weight Management Program gives diet, exercise and lifestyle advice via a phone app or online, to patients referred by their GP with a high BMI plus hypertension, diabetes or both.
Weiterlesen »
‘Godzilla’ of weight-loss jabs could be ‘best so far – helping slimmers shed 30% body weight’...FILE PHOTO: Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. REUTERS/Victoria Klesty/Illustration/File Photo
Weiterlesen »
Scientists discover a NEW weight loss shot that could burn twice as much fat as OzempicA new weight loss drug could ramp up fat loss, , early trial data has shown. Obese patients lost roughly 19 percent of their body weight, compared to 10 percent on Ozempic.
Weiterlesen »
Millions could ‘slash heart disease risk’ on weight-loss jabs like Wegovy – in ‘biggest breakthrough since...‘Godzilla’ of weight-loss jabs could be ‘best so far – helping slimmers shed 30% body weight’
Weiterlesen »
Excessive pregnancy weight gain and substantial postpartum weight retention common in military health care beneficiariesCompared to their civilian counterparts, excessive pregnancy weight gain is more frequent among military health care beneficiaries, in particular active duty personnel, and is associated with costly maternal/neonatal complications.
Weiterlesen »
Weight loss drug linked with reduced need for diuretics in heart failure patientsSemaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction (HFpEF) regardless of diuretic use, according to late breaking research presented at Heart Failure 2024, held 11–14 May in Lisbon,...
Weiterlesen »